Molnupiravir
Wie es das Coronavirus stoppt war bisher unklar. Experts laud Mercks Covid-19 drug molnupiravir. K Cks0vbvbcmxm Der antivirale Wirkstoff Molnupiravir könnte eine Ansteckung mit dem Corona-Virus verhindern. Molnupiravir . Merck Molnupiravir EIDD-2801MK-4482 is an investigational orally bioavailable form of a potent ribonucleoside analog in development for the treatment of COVID-19. Molnupiravir is an orally available antiviral drug candidate currently in phase III trials for the treatment of patients with COVID-19. Molnupiravir a wide-spectrum antiviral that is currently in phase 23 clinical trials for the treatment of COVID-19 is proposed to inhibit viral replication by a mechanism known as lethal. Die Einnahme von Molnupiravir habe das Risiko im Krankenhaus behandelt werden zu müssen um die. In March 2021 the companies reported preliminary results from a Phase IIa trial of molnupiravir for Covid-19. Derzeit 2021 wird in klinischen Studien ein möglicher Einsatz bei COVID-19...